Adoptive transfer of tumor-specific Th9 cells eradicates heterogeneous antigen-expressing tumor cells

被引：5
作者：
Sek, Kevin [1 ,2 ]
Chan, Cheok Weng [1 ,2 ]
Beavis, Paul A. [1 ,2 ]
Darcy, Phillip K. [1 ,2 ,3 ,4 ]
机构：
[1] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 3000, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia
[3] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia
[4] Monash Univ, Dept Immunol, Clayton, Vic, Australia
来源：
CANCER CELL | 2021年 / 39卷 / 12期
基金：
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词：
CAR-T CELLS;
D O I：
10.1016/j.ccell.2021.10.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In this issue of Cancer Cell, Xue et al. demonstrate that adoptive transfer of tumor-specific Th9 cells can eradicate established tumors containing antigen-loss-variant cells (ALVs) through both direct killing and bystander effects mediated by intratumoral accumulation of extracellular ATP (eATP) that promotes monocyte infiltration and stimulation of IFN alpha/beta production.
引用
收藏
页码：1564 / 1566
页数：3
相关论文
共 10 条
  • [1] IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor
    Adachi, Keishi
    Kano, Yosuke
    Nagai, Tomohiko
    Okuyama, Namiko
    Sakoda, Yukimi
    Tamada, Koji
    [J]. NATURE BIOTECHNOLOGY, 2018, 36 (04) : 346 - +
  • [2] Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
    Brown, Christine E.
    Alizadeh, Darya
    Starr, Renate
    Weng, Lihong
    Wagner, Jamie R.
    Naranjo, Araceli
    Ostberg, Julie R.
    Blanchard, M. Suzette
    Kilpatrick, Julie
    Simpson, Jennifer
    Kurien, Anita
    Priceman, Saul J.
    Wang, Xiuli
    Harshbarger, Todd L.
    D'Apuzzo, Massimo
    Ressler, Julie A.
    Jensen, Michael C.
    Barish, Michael E.
    Chen, Mike
    Portnow, Jana
    Forman, Stephen J.
    Badie, Behnam
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (26) : 2561 - 2569
  • [3] IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression
    Chmielewski, Markus
    Kopecky, Caroline
    Hombach, Andreas A.
    Abken, Hinrich
    [J]. CANCER RESEARCH, 2011, 71 (17) : 5697 - 5706
  • [4] IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors
    Giuffrida, Lauren
    Sek, Kevin
    Henderson, Melissa A.
    House, Imran G.
    Lai, Junyun
    Chen, Amanda X. Y.
    Todd, Kirsten L.
    Petley, Emma, V
    Mardiana, Sherly
    Todorovski, Izabela
    Gruber, Emily
    Kelly, Madison J.
    Solomon, Benjamin J.
    Vervoort, Stephin J.
    Johnstone, Ricky W.
    Parish, Ian A.
    Neeson, Paul J.
    Kats, Lev M.
    Darcy, Phillip K.
    Beavis, Paul A.
    [J]. MOLECULAR THERAPY, 2020, 28 (11) : 2379 - 2393
  • [5] The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function
    Johnson, Lexus R.
    Lee, Daniel Y.
    Eacret, Jacqueline S.
    Ye, Darwin
    June, Carl H.
    Minn, Andy J.
    [J]. CELL, 2021, 184 (19) : 4981 - +
  • [6] CD103+ cDC1 and endogenous CD8+ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function
    Kuhn, Nicholas F.
    Lopez, Andrea V.
    Li, Xinghuo
    Cai, Winson
    Daniyan, Anthony F.
    Brentjens, Renier J.
    [J]. NATURE COMMUNICATIONS, 2020, 11 (01)
  • [7] Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
    Lai, Junyun
    Mardiana, Sherly
    House, Imran G.
    Sek, Kevin
    Henderson, Melissa A.
    Giuffrida, Lauren
    Chen, Amanda X. Y.
    Todd, Kirsten L.
    Petley, Emma, V
    Chan, Jack D.
    Carrington, Emma M.
    Lew, Andrew M.
    Solomon, Benjamin J.
    Trapani, Joseph A.
    Kedzierska, Katherine
    Evrard, Maximilien
    Vervoort, Stephin J.
    Waithman, Jason
    Darcy, Phillip K.
    Beavis, Paul A.
    [J]. NATURE IMMUNOLOGY, 2020, 21 (08) : 914 - +
  • [8] Th9 Cells Represent a Unique Subset of CD4+ T Cells Endowed with the Ability to Eradicate Advanced Tumors
    Lu, Yong
    Wang, Qiang
    Xue, Gang
    Bi, Enguang
    Ma, Xingzhe
    Wang, Aibo
    Qian, Jianfei
    Dong, Chen
    Yi, Qing
    [J]. CANCER CELL, 2018, 33 (06) : 1048 - +
  • [9] Peripheral blood Th9 cells are a possible pharmacodynamic biomarker of nivolumab treatment efficacy in metastatic melanoma patients
    Nonomura, Yumi
    Otsuka, Atsushi
    Nakashima, Chisa
    Seidel, Judith A.
    Kitoh, Akihiko
    Dainichi, Teruki
    Nakajima, Saeko
    Sawada, Yu
    Matsushita, Shigeto
    Aoki, Megumi
    Takenouchi, Tatsuya
    Fujimura, Taku
    Hatta, Naohito
    Koreeda, Satoshi
    Fukushima, Satoshi
    Honda, Tetsuya
    Kabashima, Kenji
    [J]. ONCOIMMUNOLOGY, 2016, 5 (12):
  • [10] Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells
    Xue, Gang
    Zheng, Ningbo
    Fang, Jing
    Jin, Guangxu
    Li, Xiaoyin
    Dotti, Gianpietro
    Yi, Qing
    Lu, Yong
    [J]. CANCER CELL, 2021, 39 (12) : 1610 - +
1